Risk Assessment Commission Identifies Daunting Challenges

Challenges Author: KAREN YOUNG KREEGER, pp.1 Date: June 27,1994 The members of the Risk Assessment and Management Commission (RAMC), which held its first meeting last month in Washington, D.C., apparently have their work cut out for them. Hampered by a two-year delay in its formation, the commission faces a November deadline to fulfill its congressional mandate to evaluate current standards and methods of assessing environmental ha

Written byKaren Kreeger
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Challenges Author: KAREN YOUNG KREEGER, pp.1
Date: June 27,1994

The members of the Risk Assessment and Management Commission (RAMC), which held its first meeting last month in Washington, D.C., apparently have their work cut out for them. Hampered by a two-year delay in its formation, the commission faces a November deadline to fulfill its congressional mandate to evaluate current standards and methods of assessing environmental hazards and to recommend how that information should be used.

Complicating that task and one of the first priorities for the 10-member panel, according to some of the commission members and other observers, is the need to define more specifically the parameters and goals of RAMC's charge.

At stake in the commission's deliberations is more than just a blueprint for Congress and public policymakers to follow in determining and regulating such environmental hazards as air pollution and toxic wastes, says RAMC chairman Gilbert Omenn, elected ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies